Previous Close | 0.1500 |
Open | 0.0000 |
Bid | 0.1400 x 0 |
Ask | 0.2000 x 0 |
Day's Range | 0.1500 - 0.1500 |
52 Week Range | 0.0650 - 0.2300 |
Volume | 0 |
Avg. Volume | 0 |
Market Cap | 2.315M |
Beta (5Y Monthly) | -0.26 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0730 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VPA) ("Veritas" or the "Company") is pleased to announce that it expects to complete the Due Diligence process for the acquisition of Indigenous Bloom Hemp Corporation ("HempCo") within the first half of January 2021 and announce the dates and process by which the shareholders will have an opportunity to approve the completion of this transaction.Veritas interim ...
Vancouver, British Columbia--(Newsfile Corp. - September 9, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VPA) ("Veritas" or the "Company") is pleased to announce that it has entered into a business combination agreement dated September 4, 2020 (the "Business Combination Agreement") to acquire Indigenous Bloom Hemp Corporation ("HempCo") by way of a three cornered amalgamation pursuant to the provisions of the Canada Business Corporations Act. The transaction is at arm's length ...
Vancouver, British Columbia--(Newsfile Corp. - July 28, 2020) - Â Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") wishes to announces that it has entered into debt settlement agreements with directors and officers to settle debt in the amount of $94,750 by the issuance of 1,263,333 common shares at a deemed price of $0.075 per share. The shares will be subject to a four month hold period from the ...